Steve Lacerte

Principal, Director, Project Management
Sciences de la vie Gestion de projet

  • Boston
  • 200 State Street
  • Floor 15
  • Boston, MA 02109

As a seasoned life sciences engineering and facilities management leader, Steve is a Principal at Avison Young in the Project Management Group. Steve focuses on managing projects in the life sciences sector, where he brings over 36 years of experience in the industry. Steve has spent the last 6+ years serving as a Project Executive for life sciences clients in eastern Massachusetts. Throughout his career, Steve has developed a deep understanding of the business objectives of companies in the drug discovery, pharmaceutical, and biotech industries in addition to procuring decades of managerial experience. As a leader in the facilities and engineering field, his expertise lies in delivering capital program and project management to ensure operational capabilities, facilities operation and real estate management, implementing Good Manufacturing Practices (GMPs), and environmental and safety requirements.

 

Credentials & Affiliations: 

  • University of Massachusetts at Lowell - M.S. Environmental Studies (Civil Engineering), B.S. Health Education
  • Fundamentals of Bio-processing for Engineers, Worcester Polytechnic Institute
  • Leadership Development Program, Center for Creative Leadership, La Jolla, CA
  • OSHA 30-hour Construction Safety accreditation

Professional Experience:

  • 2021-Present - Avison Young - Principal, Project Management
  • 2018-2021 - STV | DPM - Project Executive, Life Sciences
  • 2016-2018 - Sanofi (Genzyme) - Sr. Director, Engineering & Project Controls
  • 2006-2016 - AstraZeneca Pharmaceuticals, LP - Sr. Director, Site Engineering & Facilities Management

Life Science Clients:

 

  • Caraway Therapeutics
  • Cellink
  • Dicerna
  • EMD Serono
  • Frequency Therapeutics
  • GlaxoSmithKline Pharmaceuticals
  • Ipsen Biosciences
  • MilliporeSigma
  • PureTech Health
  • Sanofi
  • Scholar Rock
  • SmartLabs
  • Tobin Scientific 
  • Triplet Therapeutics